Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and theor relation to estradiol receptor (ER) status
- 27 June 1997
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 262 (1-2) , 99-119
- https://doi.org/10.1016/s0009-8981(97)06542-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failureThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Expression of the p185 encoded by her2 oncogene in normal and transformed human tissuesInternational Journal of Cancer, 1990
- Epidermal growth factor receptor in human breast cancer: Correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristicsEuropean Journal of Cancer and Clinical Oncology, 1990
- Prognostic value of epidermal growth factor receptor in node-positive breast cancerBreast Cancer Research and Treatment, 1989
- Prognostic factors for recurrence and survival in human breast cancerBreast Cancer Research and Treatment, 1987
- A Mr=190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the C-erbB-2 geneBiochemical and Biophysical Research Communications, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Autophosphorylation sites on the epidermal growth factor receptorNature, 1984